FRONTEO's paper search AI system "Amanogawa" introduced at Juntendo University Graduate School of Medicine, Department of Urology and Surgery

2021.12.07 Press release

--To the press -

FRONTEO's paper search AI system "Amanogawa" introduced at Juntendo University Graduate School of Medicine, Department of Urology and Surgery

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) has a paper search AI system "Amanogawa (patent pending)" at Juntendo University Graduate School of Medicine, Department of Urological Sciences (Location: We are pleased to inform you that it was introduced in Bunkyo-ku, Tokyo, Professor: Shigeo Horie).

 

 AmanogawaIs a paper search AI system equipped with FRONTEO's original AI engine "Concept Encoder (trademark: concept encoder, reading: concept encoder)".When a researcher inputs a word, sentence, hypothesis, etc. that he / she wants to look up, AI instantly detects the paper related to the input content from the large amount of paper data published in PubMed *.The search results are plotted in a map according to the similarity of the dissertation contents, and you can grasp the whole picture of the dissertation information such as the relationship between the dissertations and the number of dissertations by theme at a glance.In addition, it has various functions such as displaying a list of search results in order of relevance, word cloud, and displaying by age, so it is efficient to search and analyze papers, which took a huge amount of time for human work. Can be done to. By utilizing AI, it is possible to find information that could not be found by conventional keyword search and information that is not biased by the searcher, realizing highly objective and comprehensive analysis in medical and drug discovery research. To do.

 

Comments from Professor Shigeo Horie, Department of Urology and Surgery, Juntendo University Graduate School of Medicine
"There are many paper search systems, but Amanogawa has a high degree of comprehensiveness of literature and can be searched by query, so it is possible to grasp various information different from keyword search. Unexpected papers are detected in related areas. It's also interesting to be able to confirm. It gives me new inspiration and supports a wealth of research ideas. "

 

 FRONTEO will continue to work on research and development so that it can contribute to the development of medicine through the provision of AI systems such as Amanogawa.

 

* PubMed: A database of biomedical papers created by the National Center for Biological Sciences in the National Library of Medicine.

 


■ About FRONTEO
 URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder", and "Looca Cross" that specialize in natural language processing to extract meaningful and important information from a huge amount of text data, and is used by companies. A data analysis company that supports business. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

■ About Concept Encoder URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc.

Email: pr_contact@fronteo.com

 

<Inquiries about Life Science AI Business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x